Baseline clinical and imaging characteristics, treatment, and predictors of 3-month mRS
| All Patients (n = 123) | mRS 0–2 (n = 68) | mRS 3–6 (n = 55) | P Value | |
|---|---|---|---|---|
| Age (yr) | 69.8 ± 15.9 | 68.9 ± 16.9 | 70.8 ± 14.7 | .727a |
| Baseline NIHSS score | 11 (6–16) | 7 (5–11.5) | 16 (14–20.75) | <.0001a |
| Female sex | 55 (44.7%) | 31 (45.6%) | 24 (43.6%) | .973b |
| Right hemisphere | 74 (47.2%) | 34 (50.0%) | 24 (43.6%) | .602b |
| Time to MRI | 3:57 ± 1:26 | 3:45 ± 1:29 | 4:12 ± 1:20 | .085c |
| DWI volume (mL) | 37.4 ± 47.7 | 16.3 ± 20.1 | 63.4 ± 58.2 | <.0001a |
| MTT volume (mL) | 129.5 ± 101.3 | 80.6 ± 78.3 | 189.9 ± 94.1 | <.0001a |
| Tmax volume (mL) | 148.1 ± 114.9 | 89.5 ± 86.5 | 217.3 ± 106.0 | <.0001a |
| Absolute mismatch (mL) | 92.7 ± 81.4 | 64.9 ± 69.1 | 127.1 ± 82.9 | <.0001a |
| Relative mismatch | 8.7 ± 21.6 | 10.9 ± 27.8 | 6.0 ± 8.8 | .541a |
| Reperfusion therapy | None: 37 (30.1%) | 22 (32.4%) | 15 (25.4%) | |
| IV-tPA: 61 (49.6%) | 36 (52.9%) | 25 (45.5%) | .200b | |
| IAT ± IV-tPA: 25 (20.3%) | 10 (14.7%) | 15 (27.3%) | ||
| Occlusion level | ICA: 24 (19.5%) | 6 (8.8%) | 18 (32.7%) | |
| MCA M1: 39 (31.7%) | 15 (22.1%) | 24 (43.6%) | <.0001b | |
| MCA M2/3: 36 (29.3%) | 24 (35.3%) | 12 (21.8%) | ||
| None: 24 (19.5%) | 23 (33.8%) | 1 (1.8%) |